Vimarsana
Biggest News Aggregation in the World

Tilde Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tilde Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tilde Sciences Today - Breaking & Trending Today

Rx Rundown: The FTC, Moderna, Publicis Health and more - Vimarsana News

Rx Rundown: The FTC, Moderna, Publicis Health and more

Check out this week’s medical marketing news, people on the move and industry chatter.

AscellaHealth and Tilde Sciences Team Up to Launch Best-in-Class Patient-Centric Program for Increas - Vimarsana News

AscellaHealth and Tilde Sciences Team Up to Launch Best-in-Class Patient-Centric Program for Increas

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, announces that Tilde Sciences, specializing in the development and commercialization of specialty pharmaceuticals, has chosen AscellaHealth’s Specialty Pharmacy, Optime Care as its exclusive distribution,...

Tilde Sciences acquires Daraprim® and Vecamyl® from Vyera Pharmaceuticals - Vimarsana News

Tilde Sciences acquires Daraprim® and Vecamyl® from Vyera Pharmaceuticals

/PRNewswire/ -- Tilde Sciences, a specialty pharmaceutical company, announced today that it has acquired two medicines, Daraprim® and Vecamyl® from Vyera...

'Pharma Bro' Martin Shkreli's former company sells rights of Daraprim - Vimarsana News

'Pharma Bro' Martin Shkreli's former company sells rights of Daraprim

As part of Vyera Pharmaceuticals’ bankruptcy, it will sell off Daraprim and hypertension drug Vecamyl to Tilde Sciences for $650,000.